Accurate data and insightful analysis of the Drug Metabolism, Pharmacokinetics (DMPK), Absorption, Distribution, Metabolism, and Excretion (ADME) properties of your compounds is a critical part of the drug discovery journey and helps you shortlist candidates with the highest chances of success in the later stages of drug development. The right partner for your DMPK ADME needs can help you reduce compound failure, identify compounds with optimal safety profiles, and minimize drug-drug interactions in later stages.

In this point of view, we discuss some DMPK strategies to avoid drug development mistakes early. These strategies have helped Syngene scientists drive cost-effective, reproducible, high-quality data for our clients, thereby enabling faster movement of molecules from bench to bedside. So far, Syngene has worked with 117 global clients, conducting nearly 3500 PK studies/year.